Literature DB >> 20207854

Facets of the Rift Valley fever outbreak in Northeastern Province, Kenya, 2006-2007.

Charles H King1, Summerpal S Kahlon, Samuel Muiruri, A Desiree Labeaud.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20207854      PMCID: PMC2829890          DOI: 10.4269/ajtmh.2010.09-0800

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
Rift Valley fever virus (RVFV) is a mosquito-borne Phlebovirus that causes periodic outbreaks of animal and human disease in Africa and the Arabian Peninsula. On the basis of its many competent vectors, its potential for aerosol transmission, and its progressive spread from East Africa to neighboring regions between 1950 and 2000, RVFV is ranked as a high-priority, emerging health threat for humans, livestock, and wildlife in all parts of the world. Rift Valley fever virus is typically maintained by vertical transmission among floodwater Aedes species. Most often, local virus propagation is reactivated as these mosquitoes emerge from temporary ponds (dambos) formed by heavy rainfall in enzootic/endemic areas.1 Successive mosquito breeding near amplifying domestic livestock (cattle, goats, or sheep) allows for local intensification of exposure by bridge vectors such as Culex. Because livestock miscarriage and mortality rates are high, humans can also become occupationally exposed to RVFV by handling infected animal tissues or by aerosolization of body fluids.2 Human RVFV infection is almost always symptomatic (see Kahlon and others, this issue), typically presenting as a syndrome of fever with nausea and arthralgias, sometimes progressing to meningoencephalitis (10%), uveitis/retinitis (10–30%), or to a hemorrhagic diathesis (1%) that is highly lethal. Combined human disease and livestock losses are frequently devastating to affected communities. Figure 1A shows persistent local flooding associated with high numbers of peri-domestic vector mosquitoes in Ijara District, NE Province, following anomalous heavy rains linked with the El-Nino/Southern Oscillation event in 2006.1 Figure 1B and C show local abundance of livestock capable of amplifying Rift Valley fever virus transmission within semi-nomadic pastoralist communities.2 Figure 1D shows severe meningismus in a patient with fever and meningoencephalitis in January 2007, later confirmed to have acute Rift Valley fever virus infection.
Figure 1.

Panel A, persistent flooding from heavy rains; Panels B and C, susceptible livestock near study site; Panel D, local resident manifesting severe meningismus during encephalitic phase of confirmed RVF. (Photo credits: A, Samuel Muiruri; B, Desirée LaBeaud; C, Charles King; D, Summerpal Kahlon). This figure appears in color at www.ajtmh.org.

Panel A, persistent flooding from heavy rains; Panels B and C, susceptible livestock near study site; Panel D, local resident manifesting severe meningismus during encephalitic phase of confirmed RVF. (Photo credits: A, Samuel Muiruri; B, Desirée LaBeaud; C, Charles King; D, Summerpal Kahlon). This figure appears in color at www.ajtmh.org.
  2 in total

1.  Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya.

Authors:  K J Linthicum; A Anyamba; C J Tucker; P W Kelley; M F Myers; C J Peters
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

2.  Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya.

Authors:  A Desiree LaBeaud; Eric M Muchiri; Malik Ndzovu; Mariam T Mwanje; Samuel Muiruri; Clarence J Peters; Charles H King
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

  2 in total
  4 in total

Review 1.  Advances in Rift Valley fever research: insights for disease prevention.

Authors:  A Desiree LaBeaud; James W Kazura; Charles H King
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

2.  Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways.

Authors:  Amy G Hise; Zachary Traylor; Noémi B Hall; Laura J Sutherland; Saidi Dahir; Megan E Ermler; Samuel Muiruri; Eric M Muchiri; James W Kazura; A Desirée LaBeaud; Charles H King; Catherine M Stein
Journal:  PLoS Negl Trop Dis       Date:  2015-03-10

3.  The sero-epidemiology of Rift Valley fever in people in the Lake Victoria Basin of western Kenya.

Authors:  Elizabeth Anne Jessie Cook; Elysse Noel Grossi-Soyster; William Anson de Glanville; Lian Francesca Thomas; Samuel Kariuki; Barend Mark de Clare Bronsvoort; Claire Njeri Wamae; Angelle Desiree LaBeaud; Eric Maurice Fèvre
Journal:  PLoS Negl Trop Dis       Date:  2017-07-07

4.  Rift Valley fever virus in small ruminants in the Democratic Republic of the Congo.

Authors:  Georges M Tshilenge; Mfumu L K Mulumba; Gerald Misinzo; Rob Noad; William G Dundon
Journal:  Onderstepoort J Vet Res       Date:  2019-10-10       Impact factor: 1.792

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.